PCOS (polycystic ovary syndrome) is not a comorbidity. It is a primary condition, the most common endocrine disorder among women of reproductive age worldwide. However, PCOS is strongly associated with a long list of comorbidities, which is likely why this question comes up so often. In medical contexts, PCOS functions as the underlying diagnosis that increases the risk of developing other conditions, from type 2 diabetes and heart disease to depression and certain cancers.
That said, recent literature increasingly recognizes PCOS as a metabolic disease, not just a reproductive one. This reclassification matters because it shifts focus toward the full-body health risks that come with it, rather than treating it solely as a fertility issue.
Why PCOS Gets Confused With a Comorbidity
The confusion makes sense. PCOS frequently appears alongside metabolic syndrome, obesity, and insulin resistance, so it can look like just another item on a list of overlapping conditions. In practice, though, PCOS is the diagnosis that drives many of those other problems. It creates a self-reinforcing cycle: excess androgens (male hormones) alter how fat cells function, which worsens insulin resistance, which causes the body to produce even more insulin. That extra insulin then suppresses a protein that normally keeps testosterone in check, so free testosterone levels climb higher, and the cycle repeats.
This loop explains why PCOS rarely shows up alone. The hormonal and metabolic disruptions it causes ripple outward into nearly every organ system.
Metabolic Syndrome and Insulin Resistance
About one-third of adolescents with PCOS meet the criteria for metabolic syndrome, compared to roughly 11% of their peers without the condition. Among those who are also obese, the numbers get much worse: nearly 70% have metabolic syndrome, over 60% have significant insulin resistance, and more than half have central obesity. Even in leaner populations, PCOS still raises metabolic risk, though the severity varies by region and body composition. One study of Italian women with PCOS found metabolic syndrome rates between 8% and 16%, well below the figures seen in American cohorts.
The practical takeaway is that PCOS and metabolic problems are deeply intertwined, but the severity depends heavily on weight and individual factors.
Type 2 Diabetes Risk
More than half of women with PCOS develop type 2 diabetes by age 40, according to the CDC. That is a striking number, and it reflects the central role insulin resistance plays in the condition. Your body’s cells become less responsive to insulin over time, forcing the pancreas to produce more and more of it. Eventually, the pancreas can’t keep up, and blood sugar levels rise.
This risk exists even for women with PCOS who are not overweight, though obesity accelerates the timeline significantly.
Heart Disease and High Blood Pressure
Women with PCOS face a higher risk of hypertension, particularly during their reproductive years. The “classic” PCOS phenotype, characterized by irregular periods and elevated androgens, carries roughly a 50% higher rate of high blood pressure compared to other PCOS subtypes. In one large study of South Asian women, having both PCOS and type 2 diabetes was associated with six times the odds of hypertension compared to healthy controls.
The key risk factors for developing high blood pressure within the PCOS population are age over 30, obesity, impaired glucose tolerance, type 2 diabetes, and a family history of hypertension. These are largely the same risk factors that matter in the general population, but PCOS accelerates and amplifies them.
Fatty Liver Disease
Roughly 40% of women with PCOS have non-alcoholic fatty liver disease (now called metabolic dysfunction-associated steatotic liver disease), compared to 6% to 33% in the general population. About 7% already show signs of liver fibrosis, which is scarring that can progress to more serious liver damage over time. The mechanism is straightforward: excess androgens promote fat accumulation in the liver, and insulin resistance makes it worse by driving ectopic fat deposits into organs that aren’t designed to store it.
Endometrial Cancer
Women with PCOS are about four times more likely to develop endometrial cancer than women without it. Among premenopausal women specifically, the risk jumps to five times higher. Some studies have reported hazard ratios as high as 10 to 14 times the normal risk, though these come from smaller datasets.
The connection is chronic anovulation. When you don’t ovulate regularly, your body produces estrogen without the counterbalancing effect of progesterone. Over months and years, that unopposed estrogen stimulates the uterine lining, promoting abnormal cell growth that can eventually become cancerous.
Depression and Anxiety
The prevalence of depression among women with PCOS averages 31%, with individual studies reporting rates anywhere from 16% to 56%. By comparison, depression affects roughly 3% to 6% of the general population. Women with PCOS are about 2.5 times more likely to experience depression than women without it, and when researchers looked at moderate to severe symptoms specifically, the odds were more than four times higher.
The causes are both biological and psychological. Hormonal imbalances directly affect mood regulation, while the visible symptoms of PCOS, such as acne, excess hair growth, weight gain, and fertility struggles, take a significant emotional toll.
Sleep Apnea
Obstructive sleep apnea shows a clear pattern in PCOS that depends almost entirely on weight. In lean women with PCOS, the prevalence of sleep apnea is essentially zero. In obese women with PCOS, it jumps to between 33% and 41%. The 38-percentage-point gap between lean and obese PCOS patients suggests that excess weight, rather than the hormonal disorder itself, is the primary driver of sleep-disordered breathing in this population.
Pregnancy Complications
Women with PCOS who become pregnant face nearly three times the risk of gestational diabetes and close to twice the risk of preeclampsia compared to pregnant women without the condition. These risks hold even after accounting for obesity and the use of assisted reproductive technology, meaning PCOS itself is an independent contributor. When gestational diabetes and PCOS occur together, the risk of preeclampsia climbs to two to three times higher than in women with gestational diabetes alone.
How These Risks Connect
Nearly all of the comorbidities linked to PCOS trace back to the same core problem: insulin resistance and androgen excess feeding off each other. Excess androgens change how fat is stored and metabolized, promoting visceral fat and fat deposits in the liver and muscles. That fat worsens insulin resistance, which drives the body to produce more insulin, which in turn suppresses the protein that binds testosterone, leaving more free testosterone circulating. Each comorbidity is essentially a downstream consequence of this cycle playing out in different tissues.
This is why managing insulin resistance, whether through weight loss, physical activity, or medication, tends to improve multiple PCOS symptoms simultaneously. Addressing the root of the cycle has cascading benefits across cardiovascular, reproductive, metabolic, and mental health outcomes.